182 related articles for article (PubMed ID: 18375953)
1. Characterization of the conformational alterations, reduced anticoagulant activity, and enhanced antiangiogenic activity of prelatent antithrombin.
Richard B; Swanson R; Schedin-Weiss S; Ramirez B; Izaguirre G; Gettins PG; Olson ST
J Biol Chem; 2008 May; 283(21):14417-29. PubMed ID: 18375953
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic antithrombin blocks the heparan sulfate-dependent binding of proangiogenic growth factors to their endothelial cell receptors: evidence for differential binding of antiangiogenic and anticoagulant forms of antithrombin to proangiogenic heparan sulfate domains.
Zhang W; Swanson R; Xiong Y; Richard B; Olson ST
J Biol Chem; 2006 Dec; 281(49):37302-10. PubMed ID: 17040907
[TBL] [Abstract][Full Text] [Related]
3. A novel anti-angiogenic form of antithrombin with retained proteinase binding ability and heparin affinity.
Larsson H; Akerud P; Nordling K; Raub-Segall E; Claesson-Welsh L; Björk I
J Biol Chem; 2001 Apr; 276(15):11996-2002. PubMed ID: 11278631
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
[TBL] [Abstract][Full Text] [Related]
5. Separation of latent, prelatent, and native forms of human antithrombin by heparin affinity high-performance liquid chromatography.
Karlsson G; Winge S
Protein Expr Purif; 2004 Feb; 33(2):339-45. PubMed ID: 14711523
[TBL] [Abstract][Full Text] [Related]
6. The heparin-binding site of antithrombin is crucial for antiangiogenic activity.
Zhang W; Swanson R; Izaguirre G; Xiong Y; Lau LF; Olson ST
Blood; 2005 Sep; 106(5):1621-8. PubMed ID: 15905187
[TBL] [Abstract][Full Text] [Related]
7. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
[TBL] [Abstract][Full Text] [Related]
8. Oxidized antithrombin is a dual inhibitor of coagulation and angiogenesis: Importance of low heparin affinity.
Azhar A; Khan MS; Swaminathan A; Naseem A; Chatterjee S; Jairajpuri MA
Int J Biol Macromol; 2016 Jan; 82():541-50. PubMed ID: 26554332
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic forms of antithrombin specifically bind to the anticoagulant heparin sequence.
Schedin-Weiss S; Richard B; Hjelm R; Olson ST
Biochemistry; 2008 Dec; 47(51):13610-9. PubMed ID: 19035835
[TBL] [Abstract][Full Text] [Related]
10. Anti-Tumor Functions of Prelatent Antithrombin on Glioblastoma Multiforme Cells.
Peñas-Martínez J; Luengo-Gil G; Espín S; Bohdan N; Ortega-Sabater C; Ródenas MC; Zaragoza-Huesca D; López-Andreo MJ; Plasencia C; Vicente V; Carmona-Bayonas A; Martínez-Martínez I
Biomedicines; 2021 May; 9(5):. PubMed ID: 34067120
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.
Desai UR; Petitou M; Björk I; Olson ST
Biochemistry; 1998 Sep; 37(37):13033-41. PubMed ID: 9737884
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of recombinant human antithrombin containing the prelatent form in Chinese hamster ovary cells.
Mochizuki S; Miyano K; Kondo M; Hirose M; Masaki A; Ohi H
Protein Expr Purif; 2005 Jun; 41(2):323-31. PubMed ID: 15866718
[TBL] [Abstract][Full Text] [Related]
13. The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation.
Richard B; Swanson R; Olson ST
J Biol Chem; 2009 Oct; 284(40):27054-64. PubMed ID: 19661062
[TBL] [Abstract][Full Text] [Related]
14. Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor.
Björk I; Ylinenjärvi K; Olson ST; Bock PE
J Biol Chem; 1992 Jan; 267(3):1976-82. PubMed ID: 1730729
[TBL] [Abstract][Full Text] [Related]
15. Conformational activation of antithrombin by heparin involves an altered exosite interaction with protease.
Izaguirre G; Aguila S; Qi L; Swanson R; Roth R; Rezaie AR; Gettins PG; Olson ST
J Biol Chem; 2014 Dec; 289(49):34049-64. PubMed ID: 25331949
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement.
Streusand VJ; Björk I; Gettins PG; Petitou M; Olson ST
J Biol Chem; 1995 Apr; 270(16):9043-51. PubMed ID: 7721817
[TBL] [Abstract][Full Text] [Related]
17. Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin.
Izaguirre G; Swanson R; Raja SM; Rezaie AR; Olson ST
J Biol Chem; 2007 Nov; 282(46):33609-33622. PubMed ID: 17875649
[TBL] [Abstract][Full Text] [Related]
18. Conformational equilibrium of the reactive center loop of antithrombin examined by steady state and time-resolved fluorescence measurements: consequences for the mechanism of factor Xa inhibition by antithrombin-heparin complexes.
Futamura A; Beechem JM; Gettins PG
Biochemistry; 2001 Jun; 40(22):6680-7. PubMed ID: 11380263
[TBL] [Abstract][Full Text] [Related]
19. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
[TBL] [Abstract][Full Text] [Related]
20. Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis.
Raja SM; Chhablani N; Swanson R; Thompson E; Laffan M; Lane DA; Olson ST
J Biol Chem; 2003 Apr; 278(16):13688-95. PubMed ID: 12591924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
